Boda Ying*, Hong Huang†, Hongfei Li*, Meng Song*, Sizhan Wu*, Hongliang Ying†
Oncology Research, Vol.25, No.9, pp. 1463-1470, 2017, DOI:10.3727/096504017X14878518291077
Abstract Procaine (PCA) is a conventional chemotherapeutic agent for osteosarcoma. Recent studies have proposed
that the growth-inhibitory effect of PCA is through regulation of microRNAs (miRNAs). miR-133b has been
proven to be a tumor suppressor in osteosarcoma, but whether it is involved in the antitumor effects of PCA on
osteosarcoma has not been investigated. In this study, we aimed to explore the effects of PCA on osteosarcoma
MG63 cells by regulation of miR-133b, as well as its underlying mechanisms. MG63 cells were treated with
different concentrations of PCA, and cell viability, apoptosis, and miR-133b expression were… More >